First experience with BAK-free travoprost 0.004% in topical glaucoma medication

OBJECTIVES: Benzalkonium chloride (BAK)-free travoprost 0.004% (Travatan Z(®), Alcon Laboratories, Inc, Fort Worth, TX) is a new formulation that was developed with the aim of creating a formulation of travoprost that would maintain the intraocular pressure (IOP)-lowering efficacy and have an improv...

Descripción completa

Detalles Bibliográficos
Autores principales: Gado, Ahmed Salah, Macky, Tamer Ahmed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3259093/
https://www.ncbi.nlm.nih.gov/pubmed/22259229
http://dx.doi.org/10.2147/OPTH.S24983

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3259093/
https://www.ncbi.nlm.nih.gov/pubmed/22259229
http://dx.doi.org/10.2147/OPTH.S24983

Ejemplares similares